Anti-tumor effects of a human VEGFR-2-based DNA vaccine in mouse models

Genetic Vaccines and Therapy

Volumn 7, Issue , 2009, Pages

  Xie, Ke ^a   Bai, Rui Zhen ^a   Wu, Yang ^a   Liu, Quan ^a   Liu, Kang ^a   Wei, Yu Quan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DNA VACCINE; HUMAN VASCULOTROPIN RECEPTOR 2; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; BLOOD CELL COUNT; BREAST CANCER; CANCER IMMUNIZATION; COLON CARCINOMA; CONTROLLED STUDY; DRUG EFFICACY; FEEDING BEHAVIOR; FEMALE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MOUSE; NONHUMAN; SURVIVAL RATE; TOXICITY TESTING; WEIGHT REDUCTION;

EID: 67651250047     PISSN: None     EISSN: 14790556     Source Type: Journal    
DOI: 10.1186/1479-0556-7-10     Document Type: Article

References (30)

1. Bouck N Stellmach V Hsu SC How tumors become angiogenic Adv Cancer Res 1996, 69:135-174 8791681
2. Ferrara N VEGF: An update on biological and therapeutic aspects Curr Opin Biotechnol 2000, 11:617-624 11102799
3. Folkman J Angiogenesis and angiogenesis inhibition: An overview Exs 1997, 79:1-8 9002217
4. Ferrara N Gerber HP LeCouter J The biology of VEGF and its receptors Nat Med 2003, 9:669-676 12778165
5. Shibuya M Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis J Biochem Mol Biol 2006, 39:469-478 17002866
6. Kornberg TB Krasnow MA The Drosophila genome sequence: Implications for biology and medicine Science 2000, 287:2218-2220 10731136
7. Kochenderfer JN Gress RE A comparison and critical analysis of preclinical anticancer vaccination strategies Exp Biol Med (Maywood) 2007, 232:1130-1141 17895521
8. Prud'homme GJ DNA vaccination against tumors J Gene Med 2005, 7:3-17 15538731
9. Park JH Kim CJ Lee JH Shin SH Chung GH Jang YS Effective immunotherapy of cancer by DNA vaccination Mol Cells 1999, 9:384-391 10515601
10. Stevenson FK Ottensmeier CH Johnson P Zhu D Buchan SL McCann KJ Roddick JS King AT McNicholl F Savelyeva N Rice J DNA vaccines to attack cancer Proc Natl Acad Sci USA 2004, 101(Suppl 2):14646-14652 521995 15292504
11. Cho HI Niu G Bradley N Celis E Optimized DNA vaccines to specifically induce therapeutic CD8 T cell responses against autochthonous breast tumors Cancer Immunol Immunother 2008, 57:1695-1703 18253731
12. Shi FF Gunn GR Snyder LA Goletz TJ Intradermal vaccination of MUC1 transgenic mice with MUC1/IL-18 plasmid DNA suppresses experimental pulmonary metastases Vaccine 2007, 25:3338-3346 17292519
13. Westermann J Nguyen-Hoai T Baldenhofer G Hopken UE Lipp M Dorken B Pezzutto A CCL19 (ELC) as an adjuvant for DNA vaccination: Induction of a TH1-type T-cell response and enhancement of antitumor immunity Cancer Gene Ther 2007, 14:523-532 17384577
14. Sellins K Fradkin L Liggitt D Dow S Type I interferons potently suppress gene expression following gene delivery using liposome(-)DNA complexes Mol Ther 2005, 12:451-459 15950543
15. U'Ren L Kedl R Dow S Vaccination with liposome - DNA complexes elicits enhanced antitumor immunity Cancer Gene Ther 2006, 13:1033-1044 16841080
16. Dow SW Fradkin LG Liggitt DH Willson AP Heath TD Potter TA Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously J Immunol 1999, 163:1552-1561 10415059
17. Gorelik E Wiltrout RH Okumura K Habu S Herberman RB Role of NK cells in the control of metastatic spread and growth of tumor cells in mice Int J Cancer 1982, 30:107-112 7118294
18. He QM Wei YQ Tian L Zhao X Su JM Yang L Lu Y Kan B Lou YY Huang MJ et al Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice J Biol Chem 2003, 278:21831-21836 12651849
19. Wei YQ Wang QR Zhao X Yang L Tian L Lu Y Kang B Lu CJ Huang MJ Lou YY et al Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine Nat Med 2000, 6:1160-1166 11017149
20. Wei Y Zhao X Kariya Y Fukata H Teshigawara K Uchida A Induction of autologous tumor killing by heat treatment of fresh human tumor cells: involvement of gamma delta T cells and heat shock protein 70 Cancer Res 1996, 56:1104-1110 8640768
21. Hoffmann J Schirner M Menrad A Schneider MR A highly sensitive model for quantification of in vivo tumor angiogenesis induced by alginate-encapsulated tumor cells Cancer Res 1997, 57:3847-3851 9288798
22. Liu JY Wei YQ Yang L Zhao X Tian L Hou JM Niu T Liu F Jiang Y Hu B et al Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2 Blood 2003, 102:1815-1823 12750177
23. Yi T Wei YQ Tian L Zhao X Li J Deng HX Wen YJ Zou CH Tan GH Kan B et al Humoral and cellular immunity induced by tumor cell vaccine based on the chicken xenogeneic homologous matrix metalloproteinase-2 Cancer Gene Ther 2007, 14:158-164 17124509
24. Zhou H Luo Y Mizutani M Mizutani N Reisfeld R Xiang R T cell-mediated suppression of angiogenesis results in tumor protective immunity Blood 2005, 106:2026-2032 15920006
25. Prewett M Huber J Li Y Santiago A O'Connor W King K Overholser J Hooper A Pytowski B Witte L et al Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors Cancer Res 1999, 59:5209-5218 10537299
26. Wood JM Bold G Buchdunger E Cozens R Ferrari S Frei J Hofmann F Mestan J Mett H O'Reilly T et al PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration Cancer Res 2000, 60:2178-2189 10786682
27. Angelov L Salhia B Roncari L McMahon G Guha A Inhibition of angiogenesis by blocking activation of the vascular endothelial growth factor receptor 2 leads to decreased growth of neurogenic sarcomas Cancer Res 1999, 59:5536-5541 10554031
28. Millauer B Shawver LK Plate KH Risau W Ullrich A Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant Nature 1994, 367:576-579 8107827
29. Niethammer AG Xiang R Becker JC Wodrich H Pertl U Karsten G Eliceiri BP Reisfeld RA A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth Nat Med 2002, 8:1369-1375 12415261
30. Dass CR Choong PF Selective gene delivery for cancer therapy using cationic liposomes: In vivo proof of applicability J Control Release 2006, 113:155-163 16764960